Antibiotic-Resistant Shiga Toxin E. coli Raises Food
Quick Facts
Why Is Antibiotic-Resistant STEC O157 a Public Health Concern?
Shiga toxin-producing E. coli O157 is a major cause of severe foodborne illness, especially bloody diarrhea and hemolytic uremic syndrome, a kidney-threatening complication. In the Future Microbiology study, researchers analyzed 1,995 U.S. clinical isolates reported through CDC surveillance from 2010 to 2021 and found that 81.8% were susceptible to all tested antimicrobials.
The concerning signal was not that STEC O157 suddenly became broadly untreatable, but that resistance increased over time for tetracycline, sulfisoxazole, chloramphenicol, and trimethoprim-sulfamethoxazole. Because antibiotics are generally not recommended for suspected STEC infection, these resistance patterns may point to selective pressure outside the patient encounter, including food-animal, environmental, or mixed microbial reservoirs.
Should People With E. coli Infection Take Antibiotics?
CDC clinical guidance warns that antimicrobial treatment for suspected STEC infection may increase the risk of hemolytic uremic syndrome, especially when Shiga toxin is involved. Anti-diarrheal medicines are also discouraged in STEC because slowing the gut may increase toxin-related complications.
This makes diagnosis important. Severe stomach cramps, bloody diarrhea, persistent vomiting, dehydration, or reduced urination after diarrheal illness should prompt medical care. Clinicians may order stool testing for Shiga toxin or STEC genes, monitor kidney function and blood counts, and decide whether hospital-based fluids or observation are needed.
How Can Families Reduce Shiga Toxin E. coli Risk?
STEC O157 can spread through undercooked ground beef, contaminated produce, raw milk, untreated water, person-to-person transmission, and contact with ruminants or their environments. CDC estimates that STEC O157 causes about 97,000 illnesses, 3,270 hospitalizations, and 30 deaths each year in the United States.
Prevention is still the strongest tool. Cook ground meats to safe internal temperatures, wash hands after bathroom use and animal contact, keep raw meat separate from ready-to-eat foods, wash produce under running water, and avoid unpasteurized milk or juice. For public health agencies, the study supports continued genomic and antimicrobial-resistance surveillance across human, food, animal, and environmental systems.
Frequently Asked Questions
Shiga toxin-producing E. coli, or STEC, is a group of E. coli bacteria that make toxins capable of causing severe diarrhea and, in some cases, hemolytic uremic syndrome.
CDC guidance notes that antimicrobial treatment may increase the risk of hemolytic uremic syndrome in suspected STEC infection, so treatment decisions should be made by a clinician after appropriate testing and assessment.
Seek urgent medical care for bloody diarrhea, severe abdominal pain, signs of dehydration, reduced urination, unusual bruising, extreme fatigue, or symptoms in a young child, older adult, pregnant person, or immunocompromised patient.
References
- Bhatta T, Varga C. Assessing antimicrobial resistance in Shiga toxin-producing Escherichia coli O157 isolates from human clinical cases in the United States, 2010–2021. Future Microbiology. 2026. https://doi.org/10.1080/17460913.2026.2671606
- Centers for Disease Control and Prevention. Treatment of E. coli Infection. https://www.cdc.gov/ecoli/treatment/index.html
- Centers for Disease Control and Prevention. Technical Information: E. coli Infection. https://www.cdc.gov/ecoli/php/technical-info/index.html
- U.S. Food and Drug Administration. Veterinary Feed Directive. https://www.fda.gov/animal-veterinary/development-approval-process/veterinary-feed-directive-vfd